Tolerability and safety aspects of mirtazapine

Human Psychopharmacology

Volumn 17, Issue SUPPL. 1, 2002, Pages

  Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antidepressants; Mirtazapine; Pharmacology; Safety; Tolerability

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; MIANSERIN; SEROTONIN ANTAGONIST;

AFFECTIVE NEUROSIS; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP PATTERN; TRANQUILIZING ACTIVITY; VOMITING; WEIGHT GAIN; BODY WEIGHT; REVIEW; SEXUAL BEHAVIOR; SLEEP;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; DEPRESSIVE DISORDER; HUMAN; MIANSERIN; SEROTONIN ANTAGONISTS; SEX BEHAVIOR; SLEEP; HUMANS; SEXUAL BEHAVIOR;

EID: 0036082599     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.388     Document Type: Article

References (18)

1. Mirtazapine compared with paroxetine in major depression
2. Sexual functioning in depressed outpatients taking mirtazapine
3. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission
4. 1A mediated serotonergic neurotransmission
5. 2-selective adrenoceptor antagonist Org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission
6. The effects of mirtazapine on the interactions between central noradrenergic and serotonergic systems
7. Mirtazapine substitution in SSRI-induced sexual dysfunction
8. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features
9. Noradrenergic modulation of central serotonergic neurotransmission: Acute and long-term actions of mirtazapine
10. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine
11. Efficacy and tolerability of mirtazapine versus citalopram: A double-blind, randomized study in patients with major depressive disorder
12. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline
13. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults
14. Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens
15. Effects of mirtazapine on sleep polygraphic variables in major depression
16. Antidepressant treatment of the depressed patient with insomnia
17. Mirtazapine in relapse prevention: A double-blind placebo-controlled study in depressed outpatients
18. Mirtazapine: Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder